Finance > Venture Deals Database > Venture Transactions Database > Monthly Deals (All) > June 2023 VC Transactions
Vernal Biosciences

Tech Company Financing Transactions

Vernal Biosciences Funding Round

Ampersand Capital Partners, Charles River Laboratories and Dynamk Capital participated in a $20 million Series A venture round for Vernal Biosciences. The round was announced on 6/22/2023.

Transaction Overview

Company Name

Vernal Biosciences

Announced On

6/22/2023

Transaction Type

Venture Equity

Amount

$20,000,000

Round

Series A

Investors

Ampersand Capital Partners (Lead Investor) (David Anderson)

Charles River Laboratories (Lead Investor)

Dynamk Capital (Gustavo Mahler)

Vermont Center for Emerging Technologies

Proceeds Purpose

Vernal Biosciences labs in Colchester are making mRNA for research purposes only. But, starting in August, the company is gearing up to produce mRNA that can be injected into people for clinical trials. To fund this expansion, Vernal has secured $20 million from its four main investors, which represents a nearly doubling of funds those investors previously committed to the company.

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

261 Mountain View Drive
Burlington, VT 05446
USA

Phone

Undisclosed

Website

www.vernal.bio

Email Address

Undisclosed

Overview

We are passionate about channeling Vernal's technology and the hard work of our team to democratize mRNA R&D by making mRNA readily available to more researchers and companies. We believe that science matters more than ever and that mRNA will open many more doors for science to change the lives of humans everywhere. To help fulfill this vision, Vernal is committed to increasing access to the supply of quality mRNA.

Profile

Social Media

Vernal Biosciences Company Twitter Account

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Christian Cobaugh

Browse more venture capital transactions:

Prev: 6/22/2023: Tagworks Pharmaceuticals venture capital transaction
Next: 6/22/2023: Look Up Space venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to record all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary